Twin Focus Capital Partners’s Immunogen Inc IMGN Stock Holding History

Twin Focus Capital Partners’s Portfolio IMGN Stock Details IMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-31,875	Closed	-$945K	–	165
2023 Q4	$945K	Sell	31,875 -32,000	-50%	-$637K	0.19%	73
2023 Q3	$1.01M	Hold	63,875	–	–	0.23%	67
2023 Q2	$1.21M	Sell	63,875 -30,000	-32%	-$354K	0.24%	65
2023 Q1	$360K	Hold	93,875	–	–	0.07%	138
2022 Q4	$466K	Sell	93,875 -138	-0.1%	-$748	0.1%	110
2022 Q3	$449K	Hold	94,013	–	–	0.11%	101
2022 Q2	$423K	Sell	94,013 -55	-0.1%	-$239	0.1%	113
2022 Q1	$448K	Hold	94,068	–	–	0.09%	119
2021 Q4	$698K	Hold	94,068	–	–	0.14%	82
2021 Q3	$533K	Hold	94,068	–	–	0.12%	89
2021 Q2	$620K	Hold	94,068	–	–	0.14%	83
2021 Q1	$762K	Sell	94,068 -10,000	-10%	-$81.7K	0.22%	65
2020 Q4	$671K	Hold	104,068	–	–	0.21%	67
2020 Q3	$375K	Hold	104,068	–	–	0.14%	86
2020 Q2	$479K	Hold	104,068	–	–	0.19%	70
2020 Q1	$355K	Buy	104,068 +193	+0.2%	+$844	0.16%	91
2019 Q4	$530K	Sell	103,875 -8,998	-8%	-$30.5K	0.17%	94
2019 Q3	$273K	Hold	112,873	–	–	0.11%	122
2019 Q2	$245K	Hold	112,873	–	–	0.1%	116
2019 Q1	$306K	Hold	112,873	–	–	0.14%	80
2018 Q4	$542K	Hold	112,873	–	–	0.24%	56
2018 Q3	$1.07M	Hold	112,873	–	–	0.55%	37
2018 Q2	$1.1M	Hold	112,873	–	–	0.56%	37
2018 Q1	$1.19M	Sell	112,873 -343	-0.3%	-$3.39K	0.59%	37
2017 Q4	$726K	Hold	113,216	–	–	0.37%	46
2017 Q3	$866K	Hold	113,216	–	–	0.45%	45
2017 Q2	$805K	Hold	113,216	–	–	0.44%	44
2017 Q1	$438K	Hold	113,216	–	–	0.26%	53
2016 Q4	$231K	Hold	113,216	–	–	0.15%	68
2016 Q3	$303K	Hold	113,216	–	–	0.21%	55
2016 Q2	$349K	Hold	113,216	–	–	0.28%	52
2016 Q1	$965K	Hold	113,216	–	–	0.91%	27
2015 Q4	$1.54M	Sell	113,216 -7,325	-6%	-$90.2K	1.55%	20
2015 Q3	$1.16M	Hold	120,541	–	–	1.48%	18
2015 Q2	$1.73M	Sell	120,541 -20,000	-14%	-$220K	1.95%	10
2015 Q1	$1.26M	Buy	140,541 +439	+0.3%	+$3.18K	0.99%	18
2014 Q4	$855K	Sell	140,102 -378	-0.3%	-$3.46K	1%	19
2014 Q3	$1.49M	Buy	140,480 +480	+0.3%	+$5.43K	1.46%	10
2014 Q2	$1.66M	Hold	140,000	–	–	1.86%	10
2014 Q1	$2.09M	Hold	140,000	–	–	2.48%	8
2013 Q4	$2.05M	Hold	140,000	–	–	2.03%	9
2013 Q3	$2.38M	Sell	140,000 -60,000	-30%	-$1.05M	2.27%	10
2013 Q2	$3.32M	Buy	+200,000	New	+$3.24M	3.41%	7

Other funds holding IMGN

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Twin Focus Capital Partners's IMGN Position: Q1 2024 in Review

Twin Focus Capital Partners sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 31,875 shares — an estimated $945K sold.

Twin Focus Capital Partners first reported a position in IMGN in Q2 2013 and held it in 43 quarters. The position peaked at $3.32M in Q2 2013. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

Twin Focus Capital Partners reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
Twin Focus Capital Partners sold 31,875 Immunogen Inc shares in Q1 2024, an estimated $945K.
Twin Focus Capital Partners first reported a position in Immunogen Inc in Q2 2013 and held it in 43 quarters.
Twin Focus Capital Partners's Immunogen Inc position peaked at $3.32M in Q2 2013.
3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Twin Focus Capital Partners's 13F filing for Q1 2024, filed 15 May 2024.